RxSight, Inc.
USD5.05
-0.04 (-0.88%)
CEO
Ronald Kurtz
IPO Date
2021-07-30
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$5.15
Prev. Close
$5.10
Day Low
$4.94
Day High
$5.15
52W Low
$4.48
52W High
$13.65
Market Cap
$0.21B
Volume
0.12M
| -48.7 |
| 31 Dec 2023 | FY | 60.4% | -54.6% | -30.3% | -26.6% | 0.02 | 8.06 | -28.6 |
| 31 Dec 2022 | FY | 43.5% | -136.2% | -74.3% | -44.5% | 0.50 | 7.81 | -5.3 |
| 31 Dec 2021 | FY | 20.0% | -215.5% | -35.2% | -25.3% | 0.33 | 15.92 | -6.3 |
| 31 Dec 2020 | FY | 11.6% | 187.9% | -9.3% | 27.4% | -0.10 | 7.03 | 11.1 |
| 31 Dec 2019 | FY | -81.2% | 5632.3% | -41.4% | 114.3% | -0.02 | 10.67 | 2.4 |
| -11.7 |
| 30 Sept 2025 | Q3 | 79.9% | -32.4% | -3.6% | -3.2% | 0.04 | 12.74 | -9.4 |
| 30 Jun 2025 | Q2 | 74.9% | -35.0% | -4.2% | -3.8% | 0.04 | 13.93 | -11.2 |
| 31 Mar 2025 | Q1 | 74.8% | -21.6% | -2.9% | -2.6% | 0.04 | 12.68 | -31.2 |
| 31 Dec 2024 | Q4 | 71.6% | -14.8% | -2.1% | -1.9% | 0.04 | 11.36 | -58.4 |
| 30 Sept 2024 | Q3 | 55.5% | -14.0% | -2.3% | -2.0% | 0.04 | 12.67 | -77.6 |
| 30 Jun 2024 | Q2 | 69.5% | -17.4% | -2.2% | -2.0% | 0.04 | 14.33 | -89.8 |
| 31 Mar 2024 | Q1 | 70.1% | -30.8% | -5.6% | -5.0% | 0.02 | 9.20 | -51.1 |
| 31 Dec 2023 | Q4 | 61.8% | -32.1% | -5.7% | -5.0% | 0.02 | 8.06 | -39.5 |